Skip to content
Tuesday, November 17, 2026 · Today’s edition, 6:30 a.m. ETTue, Nov 17 · 6:30 a.m. editionSign inMy Desk 0EditionsSign in
SURISimplifyACTIVE

Simplify Propel Opportunities ETF

$15.70-1.66% vs prior close
15.212152-WK

Price through Nov 16, 2026 · Flows through Nov 13, 2026. Figures use the latest available records, not a live quote. Fund details retrieved Nov 16, 2026. Holdings snapshot retrieved Nov 16, 2026.

The fund is an actively managed exchange-traded fund. The Sub-Adviser concentrates the fund's investments (i.e., invests more than 25% of its net assets) in the securities of issuers in the biotechnology, pharmaceuticals, healthcare technology, and life science tools and services industries. The Sub-Adviser employs an actively managed opportunistic multi-asset strategy that focuses on common stock, preferred stock, convertible bonds, structured notes, corporate notes and bonds, and ETFs that primarily invest in the preceding security types. The fund is non-diversified.

SURI price

Source: Market tape, daily closes; price return, distributions not reinvested
Table
DateSURI close
Oct 16, 2026$16.63
Oct 19, 2026$16.53
Oct 20, 2026$16.87
Oct 21, 2026$16.89
Oct 22, 2026$16.80
Oct 23, 2026$16.63
Oct 26, 2026$16.74
Oct 27, 2026$16.84
Oct 28, 2026$17.00
Oct 29, 2026$17.24
Oct 30, 2026$16.93
Nov 2, 2026$16.58
Nov 3, 2026$16.55
Nov 4, 2026$16.48
Nov 5, 2026$16.20
Nov 6, 2026$15.99
Nov 9, 2026$16.76
Nov 10, 2026$16.14
Nov 11, 2026$16.17
Nov 12, 2026$16.14
Nov 13, 2026$15.97
Nov 16, 2026$15.70

Daily net flows, 1M

Net outflow over the range: −$1M

  • Inflow / above zero
  • Outflow / below zero
Oct 13Oct 15Oct 19Oct 21Oct 23Oct 27Oct 29Nov 2Nov 4Nov 6Nov 10−$6.1M$0Nov 13Oct 13Oct 16Oct 21Oct 26Oct 29Nov 3Nov 6Nov 11−$6.1M$0Nov 13Oct 13Oct 21Oct 29Nov 6−$6.1M$0Nov 13
Source: Daily creation and redemption records
Show as table
LabelValue ($)
Oct 13$0
Oct 14$0
Oct 15$0
Oct 16$0
Oct 19$0
Oct 20$0
Oct 21$0
Oct 22$0
Oct 23$0
Oct 26−$502.3K
Oct 27$0
Oct 28$0
Oct 29$0
Oct 30$0
Nov 2$0
Nov 3$0
Nov 4$0
Nov 5$0
Nov 6$0
Nov 9$0
Nov 10$4.8M
Nov 11$1.3M
Nov 12−$6.1M
Nov 13$0
The desk’s read

Money is leaving — −$570K in net outflows over the past month, about 0.8% of the fund's asset base, while the price has returned -5.8% so far this year. At 2.84% a year it is not the cheapest way in — IVV has a reported fee of 0.03%.

COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH

$70Massets under management
2.84%expense ratio · $284 per $10,000 a year
−$570Knet flow, trailing month
3Kavg daily volume, 30 days
19holdings
2023listed February 7, 2023 · beta 0.52
The book at a glance
PAGP+0.2%QUIT-4.1%DCTH-3.3%COLL+0.4%OBIO-1.8%PHAT-3.0%CORT-5.1%MIST-29.8%AQST-3.8%IVA-9.8%KYTX-5.7%CMPS-8.2%CLDX-0.8%CABA-13.3%IRDPROKOCUL-3.2%PALI-8.0%—6.2%

CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS THE CHANGE IN THE LATEST AVAILABLE SNAPSHOT · TOP 40 POSITIONS

Holdings
#HoldingWeightPriceDay52-wk
1PAGPPLAINS GP HOLDINGS LP31.82%$26.42+0.2%
2QUITAchieve Life Sciences8.40%$6.06-4.1%
3DCTHDELCATH SYSTEMS6.09%$19.87-3.3%
4COLLCOLLEGIUM PHARMACEUTICAL3.38%$25.43+0.4%
5OBIOORCHESTRA BIOMED HOLDINGS2.68%$7.12-1.8%
6PHATPHATHOM PHARMACEUTICALS2.15%$5.88-3.0%
7CORTCORCEPT THERAPEUTICS2.14%$69.22-5.1%
8MISTMILESTONE PHARMACEUTICALS2.48%$0.36-29.8%
9AQSTAQUESTIVE THERAPEUTICS1.55%$3.76-3.8%
10IVAINVENTIVA SA1.65%$3.32-9.8%
11KYTXKYVERNA THERAPEUTICS INC1.31%$4.76-5.7%
12CMPSCOMPASS PATHWAYS1.16%$8.27-8.2%
13CLDXCELLDEX THERAPEUTICS0.89%$28.59-0.8%
14CABACABALETTA BIO1.01%$1.11-13.3%
15IRDOpus Genetics0.71%$4.04+1.5%

The full book, free with one sign-in.

Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus watchlists and flow alerts — unlock across the network.

Sign in to see all 19

Sector weights

  • Health Technology57.63%
  • Energy53.37%
  • Healthcare46.63%
  • Industrial Services19.99%
  • ETF10.71%
  • Technology3.88%
  • Information Technology3.62%
  • Other3.38%
  • Corporate2.84%
  • Communications2.1%
Source: Portfolio composition, latest disclosure
Show as table
ItemValue (%)
Health Technology57.63%
Energy53.37%
Healthcare46.63%
Industrial Services19.99%
ETF10.71%
Technology3.88%
Information Technology3.62%
Other3.38%
Corporate2.84%
Communications2.1%

Country weights

  • United States92.57%
  • Other7.63%
  • Canada3.49%
  • France2.31%
  • United Kingdom1.63%
  • Germany0.42%
Source: Portfolio composition, latest disclosure
Show as table
ItemValue (%)
United States92.57%
Other7.63%
Canada3.49%
France2.31%
United Kingdom1.63%
Germany0.42%
Performance
1 week-2.8%
1 month-5.6%
3 months-18.0%
6 months-12.8%
YTD-5.8%
1 year—
3 years—

PRICE RETURN, DISTRIBUTIONS NOT REINVESTED

Net flows
1 week−$68K
1 month−$570K
3 months+$1M
YTD+$1M
1 year+$1M

CREATION/REDEMPTION DOLLARS, DAILY RECORDS

Monthly net flows

  • Inflow / above zero
  • Outflow / below zero
+$403.2KAug+$737.7KSep+$342.4KOct−$68KNov+$403.2KAug+$737.7KSep+$342.4KOct−$68KNov+$403.2KAug+$737.7KSep+$342.4KOct−$68KNov
Source: Daily creation/redemption records, trailing twelve months
Show as table
LabelValue ($)
Aug$403.2K
Sep$737.7K
Oct$342.4K
Nov−$68K
The risk read
28%realized volatility, 30 days (annualized)
23%realized volatility, 1 year
-23.5%deepest fall from a peak, 1 year
-23.5%latest close versus that peak

The top holding is 31.8% of the book; the top ten carry 67%. Spread across 33+ names, it behaves like roughly 5 equally-weighted positions.

VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK

The case against SURI

Due diligence cuts both ways. These funds sit on the same shelf and beat SURI on at least one dimension that matters — the fee, the asset base, or where the money is going.

FundFeeAssetsFlow, 1MThe case
IVV iShares Core S&P 500 ETF0.03%$879.1B+$10.1B-281bp on fee · 12599× the assets · +$10.1B in over the monthHead-to-head
BBUS JPMorgan BetaBuilders U.S. Equity ETF0.02%$9.7B+$356M-282bp on fee · 139× the assets · +$356M in over the monthHead-to-head
SPTM State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF0.03%$14.2B+$235M-281bp on fee · 204× the assets · +$235M in over the monthHead-to-head
IUSG iShares Core S&P U.S. Growth ETF0.04%$32.3B+$450M-280bp on fee · 463× the assets · +$450M in over the monthHead-to-head
IUSV iShares Core S&P U.S. Value ETF0.04%$27.3B+$223M-280bp on fee · 391× the assets · +$223M in over the monthHead-to-head
Sign in to save this to The RecordA timestamped copy for the file — documentation, not advice.
ETF Dailyfrom Private Wealth Daily

ETF launches, fund research, and market coverage in your inbox every morning. Free.

Free. Every morning. Unsubscribe from any edition in one click.